Cochrane Abstracts
Molecular‐targeted first‐line therapy for advanced gastric cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Molecular‐targeted First‐line Therapy for Advanced Gastric Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434113/all/Molecular‐targeted_first‐line_therapy_for_advanced_gastric_cancer.
Molecular‐targeted first‐line therapy for advanced gastric cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434113/all/Molecular‐targeted_first‐line_therapy_for_advanced_gastric_cancer. Accessed May 17, 2025.
Molecular‐targeted first‐line therapy for advanced gastric cancer. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434113/all/Molecular‐targeted_first‐line_therapy_for_advanced_gastric_cancer
Molecular‐targeted First‐line Therapy for Advanced Gastric Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 May 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434113/all/Molecular‐targeted_first‐line_therapy_for_advanced_gastric_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Molecular‐targeted first‐line therapy for advanced gastric cancer
ID - 434113
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434113/all/Molecular‐targeted_first‐line_therapy_for_advanced_gastric_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
